Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Cash Flow-to-Debt Ratio
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd cash flow-to-debt ratio. Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) has a Cash Flow-to-Debt Ratio of -0.03x as of September 2025, meaning its operating cash flow of CN¥-17.57 Million could theoretically repay 0% of its total liabilities (CN¥567.12 Million) in one year. Check Gansu Longshenrongfa Pharmaceutical Indu (300534) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (2011–2025)
Cash flow-to-debt ratio of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd from 2011 to 2025. Historical debt coverage capacity for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd across 15 annual periods. Check 300534 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Cash Flow-to-Debt Ratio by Year (2011–2025)
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd cash flow-to-debt ratio by year from 2011 to 2025. Year-by-year debt coverage analysis for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. For the full cash flow conversion analysis, see Gansu Longshenrongfa Pharmaceutical Indu (300534) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.01x | CN¥-6.54 Million | CN¥613.42 Million | ▼ -104.2% |
| 2024 | 0.25x | CN¥170.14 Million | CN¥674.39 Million | ▲ +63.4% |
| 2023 | 0.15x | CN¥96.53 Million | CN¥625.14 Million | ▲ +102.2% |
| 2022 | 0.08x | CN¥11.43 Million | CN¥149.66 Million | ▼ -86.4% |
| 2021 | 0.56x | CN¥51.13 Million | CN¥91.24 Million | ▲ +64.3% |
| 2020 | 0.34x | CN¥43.50 Million | CN¥127.53 Million | ▼ -13.8% |
| 2019 | 0.40x | CN¥28.21 Million | CN¥71.26 Million | ▲ +123.1% |
| 2018 | 0.18x | CN¥10.23 Million | CN¥57.68 Million | ▲ +704.9% |
| 2017 | -0.03x | CN¥-2.05 Million | CN¥70.04 Million | ▼ -113.3% |
| 2016 | 0.22x | CN¥13.14 Million | CN¥59.74 Million | ▲ +73.3% |
| 2015 | 0.13x | CN¥30.60 Million | CN¥241.17 Million | ▼ -62.5% |
| 2014 | 0.34x | CN¥39.01 Million | CN¥115.40 Million | ▲ +27.1% |
| 2013 | 0.27x | CN¥35.92 Million | CN¥135.04 Million | ▼ -8.1% |
| 2012 | 0.29x | CN¥35.62 Million | CN¥123.07 Million | ▲ +114.0% |
| 2011 | 0.14x | CN¥10.16 Million | CN¥75.15 Million | — |